Comerica Bank
ESPR icon

Comerica Bank’s Esperion Therapeutics ESPR Stock Holding History

Comerica Bank’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$56 Hold
15
– – ﹤0.01% 3694
2025
Q3 		$40 Hold
15
– – ﹤0.01% 3700
2025
Q2 		$15 Hold
15
– – ﹤0.01% 3687
2025
Q1 		$22 Hold
15
– – ﹤0.01% 3675
2024
Q4 		$33 Buy
+15
New +$35 ﹤0.01% 3659
2024
Q3 		– Sell
-15
Closed -$33 – 3704
2024
Q2 		$33 Hold
15
– – ﹤0.01% 3689
2024
Q1 		$40 Buy
+15
New +$36 ﹤0.01% 3728

Other funds holding ESPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Comerica Bank's ESPR Position: Q4 2025 in Review

Comerica Bank held its Esperion Therapeutics (ESPR) position steady in Q4 2025 at 15 shares worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #3694.

Comerica Bank first reported a position in ESPR in Q1 2024 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold ESPR as of Q4 2025.

  • Comerica Bank held 15 shares of Esperion Therapeutics worth $56 as of Q4 2025.
  • Comerica Bank left its Esperion Therapeutics share count unchanged in Q4 2025.
  • Esperion Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3694 holding.
  • Comerica Bank first reported a position in Esperion Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 201 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.